| Application no. and date | 09153155.8 (espacenet) (Federated) (European Patent Register), 20040824 | | Patent/reg. no. and date | DK/EP 2060569, 20111019 | | Publication date | 20090520 | | Priority no. and date | DE 10339862, 20030829 | | EP pub. no. and date |
EP 2060569 20090520 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Straße 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 156145 | | Inventor | Sieger, Peter,
Klingenaecker 7
88441, Mittelbiberach, DE,
Sobotta, Rainer,
Ludwig-Richter-Str. 6
55218, Ingelheim, DE,
Schmid, Rolf,
Talstrasse 37
88487, Baltringen, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 7/02 (2006.01) , C07D 401/12 (2006.01) | | Title | 3-[(2-{[4-hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsyre-ethylester-methansulfonat-hemihydrat og anvendelse deraf som lægemiddel | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
